Healthcare provider profile · identity verified

Lucas D Shippee, DO

Internal Medicine · PETERBOROUGH, NH · NPI 1053339887

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	641	169
Omeprazole	Omeprazole	363	109
Losartan Potassium	Losartan Potassium	304	78
Lisinopril	Lisinopril	297	84
Levothyroxine Sodium	Levothyroxine Sodium	276	69
Metoprolol Succinate	Metoprolol Succinate	271	76
Amlodipine Besylate	Amlodipine Besylate	238	75
Simvastatin	Simvastatin	194	53
Eliquis	Apixaban	185	36
Lorazepam	Lorazepam	182	36
Hydrochlorothiazide	Hydrochlorothiazide	172	48
Tamsulosin Hcl	Tamsulosin Hcl	171	48
Rosuvastatin Calcium	Rosuvastatin Calcium	157	42
Pantoprazole Sodium	Pantoprazole Sodium	149	47
Furosemide	Furosemide	147	45
Potassium Chloride	Potassium Chloride	141	34
Atenolol	Atenolol	133	33
Gabapentin	Gabapentin	132	35
Prednisone	Prednisone	130	80
Allopurinol	Allopurinol	123	34
Oxycodone Hcl	Oxycodone Hcl	123	16
Sertraline Hcl	Sertraline Hcl	118	25
Metformin Hcl	Metformin Hcl	114	31
Warfarin Sodium	Warfarin Sodium	111	44
Metformin Hcl Er	Metformin Hcl	109	27
Albuterol Sulfate Hfa	Albuterol Sulfate	100	43
Trazodone Hcl	Trazodone Hcl	96	27
Buspirone Hcl	Buspirone Hcl	79	13
Alprazolam	Alprazolam	76	25
Citalopram Hbr	Citalopram Hydrobromide	73	22
Escitalopram Oxalate	Escitalopram Oxalate	71	20
Zolpidem Tartrate	Zolpidem Tartrate	70	22
Glipizide Er	Glipizide	69	21
Clonazepam	Clonazepam	68	12
Duloxetine Hcl	Duloxetine Hcl	68	19
Montelukast Sodium	Montelukast Sodium	67	17
Pravastatin Sodium	Pravastatin Sodium	67	18
Pregabalin	Pregabalin	66	14
Spironolactone	Spironolactone	66	13
Clopidogrel	Clopidogrel Bisulfate	64	18
Lovastatin	Lovastatin	64	14
Bupropion Hcl Sr	Bupropion Hcl	63	14
Metoprolol Tartrate	Metoprolol Tartrate	59	17
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	57	16
Fluticasone Propionate	Fluticasone Propionate	55	23
Alendronate Sodium	Alendronate Sodium	53	16
Tramadol Hcl	Tramadol Hcl	52	22
Carvedilol	Carvedilol	50	19
Glipizide	Glipizide	50	13
Finasteride	Finasteride	49	16
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	46	11
Torsemide	Torsemide	46	12
Valsartan	Valsartan	45	15
Chlorthalidone	Chlorthalidone	41	13
Synthroid	Levothyroxine Sodium	41	suppressed
Diclofenac Sodium	Diclofenac Sodium	40	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	39	13
Xarelto	Rivaroxaban	39	12
Celecoxib	Celecoxib	38	11
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	37	33
Candesartan Cilexetil	Candesartan Cilexetil	36	suppressed
Diazepam	Diazepam	36	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	36	32
Meloxicam	Meloxicam	34	suppressed
Ezetimibe	Ezetimibe	33	suppressed
Paroxetine Hcl	Paroxetine Hcl	33	suppressed
Spiriva Respimat	Tiotropium Bromide	33	suppressed
Jardiance	Empagliflozin	32	suppressed
Mirtazapine	Mirtazapine	32	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	31	suppressed
Januvia	Sitagliptin Phosphate	31	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	31	suppressed
Cephalexin	Cephalexin	30	19
Famotidine	Famotidine	30	12
Ozempic	Semaglutide	30	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	29	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	28	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	28	23
Arnuity Ellipta	Fluticasone Furoate	27	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	27	13
Donepezil Hcl	Donepezil Hcl	27	suppressed
Farxiga	Dapagliflozin Propanediol	27	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	27	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	27	27
Amitriptyline Hcl	Amitriptyline Hcl	26	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	26	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	25	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	25	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	25	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	24	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	24	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	23	suppressed
Irbesartan	Irbesartan	23	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	23	suppressed
Armour Thyroid	Thyroid,pork	22	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	22	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	22	suppressed
Enalapril Maleate	Enalapril Maleate	21	suppressed
Sildenafil Citrate	Sildenafil Citrate	21	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	21	11
Carbidopa-Levodopa	Carbidopa/Levodopa	20	suppressed
Prazosin Hcl	Prazosin Hcl	20	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	20	15
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	20	suppressed
Amoxicillin	Amoxicillin	19	15
Dilt-Xr	Diltiazem Hcl	19	suppressed
Sucralfate	Sucralfate	19	suppressed
Testosterone Cypionate	Testosterone Cypionate	19	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	19	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	18	12
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	18	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Candesartan-Hydrochlorothiazid	Candesartan/Hydrochlorothiazid	17	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	17	suppressed
Levofloxacin	Levofloxacin	17	17
Nitroglycerin	Nitroglycerin	17	11
Bupropion Xl	Bupropion Hcl	16	suppressed
Ipratropium Bromide	Ipratropium Bromide	16	suppressed
Jantoven	Warfarin Sodium	16	suppressed
Lansoprazole	Lansoprazole	16	suppressed
Propranolol Hcl Er	Propranolol Hcl	16	suppressed
Verapamil Er	Verapamil Hcl	16	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	15	suppressed
Acyclovir	Acyclovir	15	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	15	suppressed
Advair Diskus	Fluticasone Propion/Salmeterol	14	suppressed
Fluconazole	Fluconazole	14	suppressed
Nystatin	Nystatin	14	11
Ramipril	Ramipril	14	suppressed
Symbicort	Budesonide/Formoterol Fumarate	14	suppressed
Testosterone	Testosterone	14	suppressed
Dutasteride	Dutasteride	13	suppressed
Linzess	Linaclotide	13	suppressed
Memantine Hcl	Memantine Hcl	13	suppressed
Metolazone	Metolazone	13	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	13	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Carbamazepine Er	Carbamazepine	12	suppressed
Colchicine	Colchicine	12	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	12	suppressed
Humalog Mix 75-25 Kwikpen	Insulin Lispro Protamin/Lispro	12	suppressed
Invokana	Canagliflozin	12	suppressed
Ketoconazole	Ketoconazole	12	suppressed
Myrbetriq	Mirabegron	12	suppressed
Oxcarbazepine	Oxcarbazepine	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Sotalol	Sotalol Hcl	12	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	11	suppressed
Benazepril Hcl	Benazepril Hcl	11	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	11	suppressed
Carvedilol Er	Carvedilol Phosphate	11	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	11	suppressed
Fentanyl	Fentanyl	11	suppressed
Metronidazole	Metronidazole	11	suppressed
Morphine Sulfate Er	Morphine Sulfate	11	suppressed
Premarin	Estrogens, Conjugated	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error